Back
Kingsoft Cloud Holdings Ltd. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison
Sell
45
KC
Kingsoft Cloud Holdings Ltd.
Last Price:
$10.92
Seasonality Move:
11.44%
Sell
39
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$33.21
Seasonality Move:
6.21%
Sell
45
Kingsoft Cloud Holdings Ltd. (KC)
is a Sell
Is Kingsoft Cloud Holdings Ltd. a Buy, Sell or Hold?
-
The current Kingsoft Cloud Holdings Ltd. [KC] share price is $10.93. The Score for KC is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
KC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.21. The Score for RARE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KC Stock Price Chart
What is Kingsoft Cloud Holdings Ltd.'s stock price today?
-
The Kingsoft Cloud Holdings Ltd. share price today is $10.93Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KC is experiencing selling pressure, which indicates risk of future bearish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical, Inc.'s stock price today?
-
The Ultragenyx Pharmaceutical, Inc. share price today is $33.21Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
KC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.38 | Sell |
| Relative Strength Index (14 RSI): | 36.8 | Sell |
| Chaikin Money Flow: | -654102 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.25 - 12.33) | Sell |
| Bollinger Bands (100): | (11.92 - 15.16) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.65 | Buy |
| Relative Strength Index (14 RSI): | 43.13 | Sell |
| Chaikin Money Flow: | -1062961 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.65 - 35.95) | Sell |
| Bollinger Bands (100): | (29.01 - 34.13) | Buy |
KC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.36 | Sell |
| 20-day SMA: | 11.81 | Sell |
| 50-day SMA: | 12.26 | Sell |
| 200-day SMA: | 13.67 | Sell |
| 8-day EMA: | 11.27 | Sell |
| 20-day EMA: | 11.65 | Sell |
| 50-day EMA: | 12.36 | Sell |
| 200-day EMA: | 12.59 | Sell |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.62 | Sell |
| 20-day SMA: | 34.63 | Sell |
| 50-day SMA: | 33.66 | Sell |
| 200-day SMA: | 33.65 | Sell |
| 8-day EMA: | 7.38 | Buy |
| 20-day EMA: | 3.16 | Buy |
| 50-day EMA: | 1.3 | Buy |
| 200-day EMA: | 0.33 | Buy |
Kingsoft Cloud Holdings Ltd. Earnings Growth & KC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and a decrease next year of $0.05 per share.
Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.
Kingsoft Cloud Holdings Ltd. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||